Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Prognostic value of receptor tyrosine kinase-like orphan receptor (ROR) family in cancer: A meta-analysis.

Saleh RR, Antrás JF, Peinado P, Pérez-Segura P, Pandiella A, Amir E, Ocaña A.

Cancer Treat Rev. 2019 Jul;77:11-19. doi: 10.1016/j.ctrv.2019.05.006. Epub 2019 May 29.

PMID:
31174180
2.

ROR1 and ROR2 play distinct and opposing roles in endometrial cancer.

Henry CE, Llamosas E, Daniels B, Coopes A, Tang K, Ford CE.

Gynecol Oncol. 2018 Mar;148(3):576-584. doi: 10.1016/j.ygyno.2018.01.025. Epub 2018 Feb 1.

PMID:
29395309
3.

Orphan receptor tyrosine kinases ROR1 and ROR2 in hematological malignancies.

Daneshmanesh AH, Porwit A, Hojjat-Farsangi M, Jeddi-Tehrani M, Tamm KP, Grandér D, Lehmann S, Norin S, Shokri F, Rabbani H, Mellstedt H, Österborg A.

Leuk Lymphoma. 2013 Apr;54(4):843-50. doi: 10.3109/10428194.2012.731599. Epub 2012 Oct 9.

PMID:
22988987
4.

ROR1 expression as a biomarker for predicting prognosis in patients with colorectal cancer.

Zhou JK, Zheng YZ, Liu XS, Gou Q, Ma R, Guo CL, Croce CM, Liu L, Peng Y.

Oncotarget. 2017 May 16;8(20):32864-32872. doi: 10.18632/oncotarget.15860.

5.

ROR1 is a novel prognostic biomarker in patients with lung adenocarcinoma.

Zheng YZ, Ma R, Zhou JK, Guo CL, Wang YS, Li ZG, Liu LX, Peng Y.

Sci Rep. 2016 Nov 10;6:36447. doi: 10.1038/srep36447.

6.

β-catenin-independent WNT signaling and Ki67 in contrast to the estrogen receptor status are prognostic and associated with poor prognosis in breast cancer liver metastases.

Bleckmann A, Conradi LC, Menck K, Schmick NA, Schubert A, Rietkötter E, Arackal J, Middel P, Schambony A, Liersch T, Homayounfar K, Beißbarth T, Klemm F, Binder C, Pukrop T.

Clin Exp Metastasis. 2016 Apr;33(4):309-23. doi: 10.1007/s10585-016-9780-3. Epub 2016 Feb 9.

7.

Identification and characterization of rat Ror1 and Ror2 genes in silico.

Katoh M, Katoh M.

Int J Mol Med. 2005 Mar;15(3):533-8.

PMID:
15702250
8.

Targeting ROR1 identifies new treatment strategies in hematological cancers.

Karvonen H, Niininen W, Murumägi A, Ungureanu D.

Biochem Soc Trans. 2017 Apr 15;45(2):457-464. doi: 10.1042/BST20160272. Review.

PMID:
28408486
9.

Comparative genomics on ROR1 and ROR2 orthologs.

Katoh M, Katoh M.

Oncol Rep. 2005 Nov;14(5):1381-4.

PMID:
16211313
10.

ROR1, an embryonic protein with an emerging role in cancer biology.

Borcherding N, Kusner D, Liu GH, Zhang W.

Protein Cell. 2014 Jul;5(7):496-502. doi: 10.1007/s13238-014-0059-7. Epub 2014 Apr 22. Review.

11.

Receptor tyrosine kinase-like orphan receptor 1: a novel target for cancer immunotherapy.

Shabani M, Naseri J, Shokri F.

Expert Opin Ther Targets. 2015 Jul;19(7):941-55. doi: 10.1517/14728222.2015.1025753. Epub 2015 Apr 2. Review.

PMID:
25835638
12.

Expression of ROR1 has prognostic significance in triple negative breast cancer.

Chien HP, Ueng SH, Chen SC, Chang YS, Lin YC, Lo YF, Chang HK, Chuang WY, Huang YT, Cheung YC, Shen SC, Hsueh C.

Virchows Arch. 2016 May;468(5):589-95. doi: 10.1007/s00428-016-1911-3. Epub 2016 Feb 13.

PMID:
26874851
13.
14.

Expression of the Ror1 and Ror2 receptor tyrosine kinase genes during mouse development.

Al-Shawi R, Ashton SV, Underwood C, Simons JP.

Dev Genes Evol. 2001 Apr;211(4):161-71.

PMID:
11455430
15.

Ror family receptor tyrosine kinases regulate the maintenance of neural progenitor cells in the developing neocortex.

Endo M, Doi R, Nishita M, Minami Y.

J Cell Sci. 2012 Apr 15;125(Pt 8):2017-29. doi: 10.1242/jcs.097782. Epub 2012 Feb 10.

16.

The receptor tyrosine kinase ROR1--an oncofetal antigen for targeted cancer therapy.

Hojjat-Farsangi M, Moshfegh A, Daneshmanesh AH, Khan AS, Mikaelsson E, Osterborg A, Mellstedt H.

Semin Cancer Biol. 2014 Dec;29:21-31. doi: 10.1016/j.semcancer.2014.07.005. Epub 2014 Jul 25. Review.

PMID:
25068995
17.

Expression of ROR1, pAkt, and pCREB in gastric adenocarcinoma.

Chang H, Jung WY, Kang Y, Lee H, Kim A, Kim BH.

Ann Diagn Pathol. 2015 Oct;19(5):330-4. doi: 10.1016/j.anndiagpath.2015.06.010. Epub 2015 Jul 11.

PMID:
26245996
18.

Evolutionary divergence in the catalytic activity of the CAM-1, ROR1 and ROR2 kinase domains.

Bainbridge TW, DeAlmeida VI, Izrael-Tomasevic A, Chalouni C, Pan B, Goldsmith J, Schoen AP, Quiñones GA, Kelly R, Lill JR, Sandoval W, Costa M, Polakis P, Arnott D, Rubinfeld B, Ernst JA.

PLoS One. 2014 Jul 16;9(7):e102695. doi: 10.1371/journal.pone.0102695. eCollection 2014.

19.

The Ror1 receptor tyrosine kinase plays a critical role in regulating satellite cell proliferation during regeneration of injured muscle.

Kamizaki K, Doi R, Hayashi M, Saji T, Kanagawa M, Toda T, Fukada SI, Ho HH, Greenberg ME, Endo M, Minami Y.

J Biol Chem. 2017 Sep 22;292(38):15939-15951. doi: 10.1074/jbc.M117.785709. Epub 2017 Aug 8.

20.

Critical role of the Ror-family of receptor tyrosine kinases in invasion and proliferation of malignant pleural mesothelioma cells.

Saji T, Nishita M, Ogawa H, Doi T, Sakai Y, Maniwa Y, Minami Y.

Genes Cells. 2018 Jul;23(7):606-613. doi: 10.1111/gtc.12599. Epub 2018 May 29.

Supplemental Content

Support Center